
NeuroMetrix NURO
Quartalsbericht 2024-Q3
hinzugefügt 16.05.2026
NeuroMetrix P/CF 2011-2026 | NURO
P/CF Jährlich NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.22 | -0.69 | -0.244 | -12.4 | -6.87 | -1.08 | 2.31 | -0.365 | -0.3 | -0.482 | -1.73 | -2.23 | -0.636 | -0.772 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.31 | -12.4 | -1.91 |
P/CF anderer Aktien in der Medizinische Instrumente
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ICU Medical
ICUI
|
20.4 | $ 136.0 | 2.01 % | $ 3.35 B | ||
|
Atrion Corporation
ATRI
|
32 K | - | - | $ 810 M | ||
|
iRhythm Technologies
IRTC
|
62.8 | $ 114.79 | -1.52 % | $ 3.67 B | ||
|
The Cooper Companies
COO
|
20.5 | $ 62.27 | -0.45 % | $ 12.4 B | ||
|
Intuitive Surgical
ISRG
|
56.4 | $ 438.94 | 0.19 % | $ 157 B | ||
|
Luminex Corporation
LMNX
|
39.6 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-0.0678 | - | -9.52 % | $ 20.6 M | ||
|
Glaukos Corporation
GKOS
|
-465 | $ 114.14 | -5.07 % | $ 6.53 B | ||
|
Repro Med Systems
KRMD
|
431 | $ 4.19 | 2.2 % | $ 194 M | ||
|
Alcon
ALC
|
31.6 | $ 67.65 | -0.24 % | $ 40.4 B | ||
|
LeMaitre Vascular
LMAT
|
31.2 | $ 98.66 | 0.93 % | $ 2.23 B | ||
|
Antares Pharma, Inc.
ATRS
|
108 | - | - | $ 955 M | ||
|
Masimo Corporation
MASI
|
45.6 | $ 178.66 | -0.09 % | $ 9.52 B | ||
|
Cantel Medical Corp.
CMD
|
22.1 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
4.24 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
16.1 | - | -0.05 % | $ 10.3 B | ||
|
Microbot Medical
MBOT
|
-9.2 | $ 1.81 | 5.84 % | $ 82.9 M | ||
|
Ekso Bionics Holdings
EKSO
|
-2.21 | - | - | $ 28.6 M | ||
|
Milestone Scientific
MLSS
|
-8.16 | $ 0.38 | -1.21 % | $ 31.2 M | ||
|
Varian Medical Systems, Inc.
VAR
|
22.2 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
-0.0068 | $ 8.7 | 30.46 % | $ 73.8 K | ||
|
Envista Holdings Corporation
NVST
|
17.5 | $ 23.71 | 1.22 % | $ 3.98 B | ||
|
Haemonetics Corporation
HAE
|
9.58 | $ 67.07 | 2.41 % | $ 3.16 B | ||
|
Isoray
ISR
|
-1.34 | - | 0.03 % | $ 108 M | ||
|
STERIS plc
STE
|
21 | $ 216.43 | -0.06 % | $ 21.3 B | ||
|
STAAR Surgical Company
STAA
|
-27.5 | $ 33.5 | 3.17 % | $ 1.66 B | ||
|
InfuSystem Holdings
INFU
|
4.81 | $ 9.5 | -1.66 % | $ 196 M | ||
|
Utah Medical Products
UTMD
|
13.6 | $ 64.91 | 0.62 % | $ 210 M | ||
|
Teleflex Incorporated
TFX
|
52.2 | $ 132.32 | -0.32 % | $ 5.9 B | ||
|
Merit Medical Systems
MMSI
|
16.3 | $ 64.49 | 0.49 % | $ 3.82 B | ||
|
West Pharmaceutical Services
WST
|
23.3 | $ 318.51 | 0.66 % | $ 23 B | ||
|
DENTSPLY SIRONA
XRAY
|
10.7 | $ 10.03 | -1.81 % | $ 2 B | ||
|
Pulse Biosciences
PLSE
|
-31.5 | $ 26.0 | 0.42 % | $ 1.75 B | ||
|
Retractable Technologies
RVP
|
-2.84 | $ 0.68 | -4.19 % | $ 20.4 M | ||
|
Pro-Dex
PDEX
|
-89.4 | $ 65.15 | 2.57 % | $ 214 M | ||
|
Predictive Oncology
POAI
|
-0.776 | - | - | $ 31.1 M | ||
|
BioLife Solutions
BLFS
|
49.1 | $ 23.5 | -1.88 % | $ 1.12 B | ||
|
Stereotaxis
STXS
|
-12.5 | $ 1.97 | 2.34 % | $ 179 M | ||
|
Baxter International
BAX
|
11.4 | $ 19.45 | 1.38 % | $ 9.98 B | ||
|
ResMed
RMD
|
99.8 | $ 208.9 | 0.41 % | $ 30.5 B | ||
|
AtriCure
ATRC
|
27.2 | $ 28.76 | 1.66 % | $ 1.37 B | ||
|
Harvard Bioscience
HBIO
|
3.1 | $ 5.72 | 2.32 % | $ 254 M | ||
|
AngioDynamics
ANGO
|
-35.1 | $ 11.84 | -0.67 % | $ 484 M | ||
|
Becton, Dickinson and Company
BDX
|
29.1 | $ 148.55 | 0.62 % | $ 42.7 B | ||
|
Nephros
NEPH
|
20.2 | $ 3.57 | 2.88 % | $ 37.9 M | ||
|
OraSure Technologies
OSUR
|
-4.8 | $ 3.83 | 6.09 % | $ 281 M | ||
|
Repligen Corporation
RGEN
|
0.0568 | $ 115.09 | 0.02 % | $ 6.47 M |